Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/30200
Title: All-cause mortality with current and past use of antidepressants or benzodiazepines after major osteoporotic and hip fracture
Authors: de Bruin, I. J. A.
Klop, C.
Wyers, C. E.
Overbeek, J. A.
GEUSENS, Piet 
VAN DEN BERGH, Joop 
Driessen, J. H. M.
de Vries, F.
Issue Date: 2019
Publisher: SPRINGER LONDON LTD
Source: OSTEOPOROSIS INTERNATIONAL, 30(3), p. 573-581
Abstract: The SummaryIn the first year, after an osteoporotic fracture of a hip, forearm, upper arm, or spine, the dispensing rates of antidepressants and benzodiazepines increased significantly. After those fractures, recent and past use of antidepressants and benzodiazepines was associated with increased all-cause mortality; current use was not associated with mortality risk.IntroductionIt remains unclear to what extent use of antidepressants and benzodiazepines is associated with mortality risk after a major osteoporotic fracture (MOF). We aimed to study the cumulative use of antidepressants and benzodiazepines during the year after MOF or hip fracture (HF) and whether the use was associated with mortality.MethodsA cohort study was performed within the Dutch PHARMO Database Network including all patients aged 65+ with a first record of MOF (hip, humerus, forearm, and clinical vertebral fracture) between 2002 and 2011. Data were analyzed using Cox regression models, adjusted for comorbidities, and concomitant medication use and broken down to index fracture type.ResultsA total of 4854 patients sustained a first MOF, of whom 1766 patients sustained a HF. Mean follow-up was 4.6years, divided in 30-day periods. The cumulative antidepressant and benzodiazepine use during the first year after MOF increased from 10.6 to 14.7% and from 24.0 to 31.4%, respectively. Recent (31-92days before each follow-up period) and past use (>92days before) of antidepressants and benzodiazepines after MOF or HF was associated with an increased all-cause mortality risk but current use (<30days before) was not.ConclusionThere is a considerable increase in dispensing rate of antidepressants and benzodiazepines in the first year after a MOF. Recent and past use of these medications was associated with all-cause mortality. The finding that current use was not associated with mortality should be further explored and may probably be explained by the healthy survivor's bias.
Notes: [de Bruin, I. J. A.; Wyers, C. E.; van den Bergh, J. P. W.] VieCuri Med Ctr, Dept Internal Med, Venlo, Netherlands. [de Bruin, I. J. A.; Wyers, C. E.; van den Bergh, J. P. W.] Maastricht Univ, Med Ctr, Dept Internal Med, NUTRIM, Maastricht, Netherlands. [Klop, C.; Driessen, J. H. M.; de Vries, F.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands. [Overbeek, J. A.] PHARMO Inst Drug Outcome Res, Utrecht, Netherlands. [Geusens, P. P. M. M.; van den Bergh, J. P. W.] Hasselt Univ, Biomed Res Ctr, Diepenbeek, Belgium. [Geusens, P. P. M. M.] Maastricht Univ, Med Ctr, Dept Internal Med, CAPHRI,Subdiv Rheumatol, Maastricht, Netherlands. [Driessen, J. H. M.] Maastricht Univ, Med Ctr, CAPHRI, NUTRIM, Maastricht, Netherlands. [Driessen, J. H. M.; de Vries, F.] Maastricht Univ, Med Ctr, Dept Clin Pharm & Toxicol, P Debyelaan 25, Maastricht, Netherlands. [de Vries, F.] Southampton Gen Hosp, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England.
Keywords: Antidepressants .;Benzodiazepines .;Major osteoporotic fracture .;Mortality .;Osteoporosis
Document URI: http://hdl.handle.net/1942/30200
ISSN: 0937-941X
e-ISSN: 1433-2965
DOI: 10.1007/s00198-019-04851-9
ISI #: 000461576600005
Rights: The Author(s) 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http:// creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Category: A1
Type: Journal Contribution
Validations: ecoom 2020
Appears in Collections:Research publications

Files in This Item:
File Description SizeFormat 
de bruin 1.pdfPublished version466.06 kBAdobe PDFView/Open
Show full item record

SCOPUSTM   
Citations

1
checked on Sep 2, 2020

WEB OF SCIENCETM
Citations

4
checked on Apr 24, 2024

Page view(s)

38
checked on Sep 6, 2022

Download(s)

12
checked on Sep 6, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.